LUCENTIS RANIBIZUMAB
Refer to the “Also Known As” section to reference different products that include the same medication as LUCENTIS.
Drug Basics
Brand Name: LUCENTIS
Generic Name: RANIBIZUMAB
Drug Type: HUMAN PRESCRIPTION DRUG
Route: INTRAVITREAL
Dosage Form: INJECTION, SOLUTION
Data Current As Of: 2019-11-18
indications & usage
LUCENTIS is indicated for the treatment of patients with:
LUCENTIS, a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the treatment of patients with:
neovascular (wet) age-related macular degeneration (amd)
macular edema following retinal vein occlusion (rvo)
diabetic macular edema (dme)
diabetic retinopathy (dr)
myopic choroidal neovascularization (mcnv)
drug interactions
Drug interaction studies have not been conducted with LUCENTIS.
LUCENTIS intravitreal injection has been used adjunctively with PDT. Twelve of 105 (11%) patients with neovascular AMD developed serious intraocular inflammation; in 10 of the 12 patients, this occurred when LUCENTIS was administered 7 days (± 2 days) after PDT.
patient counseling information
Advise patients that in the days following LUCENTIS administration, patients are at risk of developing endophthalmitis. If the eye becomes red, sensitive to light, painful, or develops a change in vision, advise the patient to seek immediate care from an ophthalmologist [see Warnings and Precautions (5.1) ].
LUCENTIS® (ranibizumab injection) | |
Manufactured by: Genentech, Inc. A Member of the Roche Group 1 DNA Way South San Francisco, CA 94080-4990 | LUCENTIS® is a registered trademark of Genentech, Inc. ©2018 Genentech, Inc. |
Representative sample of labeling (see the HOW SUPPLIED section for complete listing):
Or Browse by Name
At Healthgrades, our Editorial Team works hard to develop complete, objective and meaningful health information to help people choose the right doctor, right hospital and right care. Our writers include physicians, pharmacists, and registered nurses with firsthand clinical experience. All condition, treatment and wellness content is medically reviewed by at least one medical professional ensuring the most accurate information possible. Learn more about our editorial process.